Type 2 Diabetes

Investigators report on a post-hoc analysis of the EMPA-REG OUTCOME trial that assesses the efficacy of the SGLT-2 inhibitor in patients with obstructive sleep apnea.

The new equation model has shown to be more accurate than the Framingham Lifetime Risk equation and Pooled Cohort Equation.

A look at the state of insulin affordability in 2020 and how the ongoing pandemic has impacted the situation.

The MiniMed 770G becomes the first system to receive approval for children in this age group.

New data shows that high BMI individuals who were in the lowest polygenic score quintile had a 5-fold greater risk of diabetes than those with low BMI and a high polygenic score.

Analysis of the UK Biobank cohort details associations between increased HbA1c levels and risk of myocardial infarction in patients regardless of sex.

Dapagliflozin and empagliflozin are shown to minimize CV events in patients with heart failure and a reduced ejection fraction.

The system maintains tight glucose control and reduces the risk of hypoglycemia.

A meta-analysis examines the differences in HbA1c management, weight loss, and other factors associated with long- versus short-acting GLP-1 receptor agonists.

A randomized trial found use of a closed-loop insulin delivery system was safe and effective in type 1 diabetics as young as 6 years of age.

New data from a pair of New Orleans-based hospitals suggests metabolic syndrome in Black patients with COVID-19 was associated with increased mortality.

Using data from a group of RCTs, investigators determined semaglutide was associated with greater reductions in HbA1c and weight loss than empagliflozin.

Data from more than 4500 diabetics suggest CAC was better at predicting CVD and all-cause mortality in women than in men.

An endocrinologist from New Jersey discusses the importance of flu shots in high-risk diabetic patients.

A study comparing 22 patients is offering a detailed overview of the effects of weight loss as a result of gastric bypass surgery and diet alone in obese patients.

An analysis of NHANES data suggests those who lost weight between early adulthood and midlife could have drastically reduced their risk of mortality.

A professor from Michigan Medicine discusses recent research from the institute and how protocols implemented at Michigan Medicine to manage the increased risk of severe outcomes associated with hyperglycemia in COVID-19.

An analysis of data from England details the increased odds of mortality associated with type 1 and type 2 diabetes in COVID-19 patients.

A single nucleotide polymorphism is associated with severe and proliferative retinopathy risk reduction by 42% and 63%, respectively.

An analysis of data from the UK and Canada has found no significant increase in below-knee amputations with SGLT2 inhibitor use versus DPP-4 inhibitor use.

Treatment with the PCSK9 Inhibitor did not increase risk of safety events, including new-onset diabetes.

Results of a web-based survey indicate the rate of new type 1 diabetes diagnoses dropped nearly 25% during the early phases of the COVID-19 pandemic.

New data suggests addition of HbA1c testing could improve youth diabetes screenings in the US compared to current screening standards.

An endocrinologist from New Jersey reflects on whether or not the management of type 2 diabetes should fall under the umbrella of primary care specialists rather than endocrinologists as diabetes become more prevalent.

An analysis of patient data from Europe suggests an increased number of infections requiring antibiotic use was tied to an elevated risk of coronary heart disease in type 1 diabetics.